Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Follicular cancer aggressive but am considered in remission after R chop. I will do maintenance immunotherapy. Will that take care of any residue cancer. Radiology thinks it may be inflammation

November 23, 2025
 · 
Be the first to react
MyLymphomaTeam

When PET scans show no change in uncertain spots on the pelvis or hip, radiation therapy isn't typically the first approach. If these areas aren't growing or showing increased activity, doctors often recommend a watch-and-wait approach with continued monitoring through regular scans and blood tests.

Radiation therapy is Show Full Answer

When PET scans show no change in uncertain spots on the pelvis or hip, radiation therapy isn't typically the first approach. If these areas aren't growing or showing increased activity, doctors often recommend a watch-and-wait approach with continued monitoring through regular scans and blood tests.

Radiation therapy is more commonly used for early-stage follicular lymphoma when cancer is limited to one or two nearby lymph node groups. It's directed at specific areas containing cancer rather than uncertain spots that remain stable on imaging.

If spots remain unclear after PET scans, your doctor might suggest additional monitoring or further imaging before deciding on treatment. Regarding maintenance immunotherapy after R-CHOP remission: Yes, maintenance therapy with targeted drugs can be used for follicular lymphoma to help keep cancer from growing too fast or returning.

Maintenance therapy may be recommended for up to two years after initial treatment is complete. This approach can address residual disease and help maintain remission longer.

However, maintenance therapy is specifically designed to target cancer cells rather than inflammation. If inflammation is the concern, your doctor would likely recommend different approaches or continued monitoring to determine if treatment is needed.

November 23, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Tucson, AZ